Training to improve attention control for treating alcohol use disorder
Official title: A Randomized Controlled Trial of Attentional Control Training for Treating Alcohol Use Disorder
Run by University of Southern Denmark · NCT05102942 · Data updated 2026-11-12
This study is testing a new game-like training program to see if it can help people with alcohol use disorder focus less on alcohol and improve their recovery when combined with regular treatments.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 268 (estimated) |
| Sponsor | University of Southern Denmark Academic / other |
| Locations | 1 site (Valby, Capital Region of Denmark) |
| Status | Recruiting |
| Started | October 1, 2022 |
| Main results expected | September 30, 2025 |
| Study ends | April 1, 2026 |
| Registry record updated | December 24, 2024 |
| Trial ID | NCT05102942 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are Danish-speaking adults aged 18 to 65 who have completed detoxification and are currently undergoing primary treatment for alcohol use disorder.
✕Probably not a fit
Patients with severe psychiatric or neurological illnesses, color-blindness, or terminal physical conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effectiveness of a gamified attentional control training program (AACTP) designed to retrain attentional biases toward alcohol cues in patients with alcohol use disorder (AUD). A total of 268 patients will be recruited from outpatient clinics in Denmark and randomly assigned to one of three treatment groups. The aim is to determine if adding AACTP to standard pharmacological and psychological treatments can enhance recovery outcomes for individuals with AUD.
Why it matters
Potential benefit: If successful, this approach could significantly reduce alcohol consumption and improve treatment outcomes for patients with alcohol use disorder.
How similar studies have gone: Previous studies have shown promise for attentional control training in community samples, but this approach is novel in clinical settings for alcohol use disorder.
Who can join: the full rules
Show full inclusion / exclusion criteria
To be eligible to participate, patients must fulfill the following criteria. Inclusion criteria: They must (1) sign written informed consent, (2) be between 18 and 65 years old (because the intervention is web-based), (3) be fluent in Danish, (4) have completed detoxification (if deemed appropriate), (5) have been admitted to primary treatment within the past eight weeks. Exclusion criteria: Be color-blind, have a severe psychiatric or neurological illness (e.g., a psychotic disorder, intellectual disability, dementia) or terminal physical illness.
Where it's running
-
KABS City
Valby, Capital Region of Denmark, Denmark Recruiting
Study contacts
- Study coordinator: Angelina I Mellentin, Ph.D
- Email: amellentin@health.sdu.dk
- Phone: +4550517901
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Imaging Mitochondrial Complex-I and Brain Metabolism in Alcohol Use Disorder
This study tests whether PET imaging with [18F]BCPP-EF and [18F]FDG can reveal differences in brain energy use between adults with alcohol use disorder and healthy controls, and whether these measures relate to relapse risk.
-
Endurance exercise to see if it lowers alcohol use in adults with AUD and ALD
A 12-week home-based cycling program added to standard care is tested to see if it reduces alcohol use and cravings in adults with alcohol use disorder and alcohol-related liver disease.
-
Do beverage cues drive craving in adults with AUD
In adults with alcohol use disorder, this study tests whether different non-alcoholic beverage cues can trigger cravings differently when people see and smell them without drinking.
-
Semaglutide for Alcohol Use Disorder and Obesity: Testing 1.0 mg and 2.0 mg vs Placebo
We’re testing two doses of semaglutide to see if they reduce alcohol craving and use in adults with alcohol use disorder and obesity compared with placebo.
-
TRIS: a mobile app with breathalyzer to support sobriety in alcohol use disorder
A smartphone app with a connected breathalyzer tests for abstinence and uses small financial incentives to encourage sobriety for adults with AUD in Brazil.
-
Body-focused mindfulness added to inpatient alcohol use disorder treatment
This trial tests whether a body-focused mindfulness program can help people with alcohol use disorder feel more connected to their bodies and reduce cravings while in inpatient care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.